Table 5 Comparison between MV patients and non-MV among patients with ILI
Studied variables | MV patients (N = 30) | Non-MV patients (N = 18) | Test of sig | P value |
|---|---|---|---|---|
Age/years | 53.1 ± 14.2 | 39.8 ± 10.9 | t-test = 3.39 | 0.001* |
Gender | N(%) | N(%) | ||
Male | 10(33.3) | 11(61.1) | X2 = 3.52 | 0.060 |
Female | 20(66.7) | 7(38.9) | ||
Smoking | ||||
Yes | 9(30.0) | 8(44.4) | X2 = 1.02 | 0.311 |
No | 21(70.0) | 10(55.6) | ||
Comorbidities | ||||
No | 9(30.0) | 17(94.4) | X2 = 19.1 | 0.002* |
Diabetes Mellitus | 7(23.3) | 1(5.60) | ||
Hypertension | 2(6.70) | 0(0.00) | ||
Ischemic heart diseases | 5(16.7) | 0(0.00) | ||
Other heart diseases | 7(23.3) | 0(0.00) | ||
Chronic chest disease | ||||
Yes | 9(30.0) | 0(0.00) | FE = 6.64 | 0.018* |
No | 21(70.0) | 18(100) | ||
Laboratory investigations | ||||
WBC | 13.3 ± 3.84 | 12.6 ± 3.82 | t-test = 0.624 | 0.535 |
Hb% | 10.2 ± 2.02 | 12.7 ± 1.97 | t-test = 4.24 | 0.001* |
Creatinine | 1.66 ± 0.75 | 1.25 ± 0.82 | U = 1.96 | 0.049 * |
BUN | 63.1 ± 16.5 | 47.3 ± 4.93 | t-test = 3.92 | 0.001* |
Albumin | 2.20 ± 0.65 | 2.62 ± 0.79 | t-test = 2.00 | 0.051 |
pH | 7.27 ± 0.14 | 7.28 ± 0.21 | t-test = 0.281 | 0.781 |
PaO2 | 49.7 ± 5.50 | 55.6 ± 5.63 | t-test = 3.55 | 0.001* |
SaO2 | 73.5 ± 5.23 | 80.9 ± 4.64 | t-test = 4.91 | 0.001* |
PaCO2 | 38.1 ± 10.1 | 38.8 ± 3.44 | t-test = 0.344 | 0.732 |
HCO3 | 16.4 ± 4.09 | 22.1 ± 1.93 | t-test = 6.42 | 0.001* |
RADS | 6.97 ± 2.05 | 5.79 ± 1.45 | U = 1.90 | 0.057 |
BWT | 2.40 ± 0.68 | 1.65 ± 0.21 | t-test = 5.49 | 0.001* |
Anion gap | 17.6 ± 8.02 | 6.55 ± 2.03 | U = 4.89 | 0.001* |
% of burn | 29.9 ± 7.59 | 21.5 ± 2.85 | t-test = 5.49 | 0.001* |
CXR | ||||
Normal | 11(36.7) | 17(94.4) | X2 15.5 | 0.001 |
Bronchopneumonia | 4(13.3) | 0(0.00) | ||
Increased BVM | 15(50.0) | 1(5.60) | ||